Kazuomi Ueshima

机构：Kindai University Sakai Hospital · ORCID：0000-0002-7577-5789

发表论文 405 篇 · 总被引 8798 次 · h-index 45

代表论文

• A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L Trial (2023 · Liver Cancer · 被引 102)
• Role of β-Catenin Activation in the Tumor Immune Microenvironment and Immunotherapy of Hepatocellular Carcinoma (2023 · Cancers · 被引 34)
• Two Distinct Characteristics of Immune Microenvironment in Human Hepatocellular Carcinoma with Wnt/β-Catenin Mutations (2023 · Liver Cancer · 被引 18)
• Non-Inflamed Tumor Microenvironment and Methylation/Downregulation of Antigen-Presenting Machineries in Cholangiocarcinoma (2023 · Cancers · 被引 16)
• Incidence of Hyper Progressive Disease in Combination Immunotherapy and Anti-Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Monotherapy for Unresectable Hepatocellular Carcinoma (2023 · Liver Cancer · 被引 14)
• Proposal of discontinuation criteria of atezolizumab plus bevacizumab after curative conversion therapy for unresectable early-to-intermediate-stage hepatocellular carcinoma: a multicenter proof-of-concept study (2025 · Journal of Gastroenterology · 被引 12)